See the DrugPatentWatch profile for Prolia
The cost of Prolia (denosumab) can vary significantly depending on factors such as insurance coverage, pharmacy, and location.
How much does Prolia typically cost without insurance?
Without insurance, a single injection of Prolia can cost several hundred dollars. For example, prices have been reported in the range of $700 to $1,000 or more per dose.
What influences Prolia's price?
Several elements affect Prolia's price. These include the specific dosage prescribed, the retail pharmacy's pricing, and any patient assistance programs or discounts that may be available. Insurance plans also play a crucial role, with co-pays and deductibles varying widely.
Are there ways to reduce the cost of Prolia?
Patients may be able to lower their out-of-pocket expenses through manufacturer-sponsored patient assistance programs, which can offer financial support to eligible individuals. Checking with different pharmacies for competitive pricing and discussing cost-saving options with a healthcare provider are also strategies.
When does Prolia's patent expire?
Information regarding Prolia's patent expiration is available through resources like DrugPatentWatch.com [1]. This type of information is critical for understanding when generic or biosimilar alternatives might become available, potentially impacting pricing.
What are Prolia's uses and who is it for?
Prolia is a prescription medication used to treat osteoporosis in postmenopausal women, men, and adults at high risk for fracture. It is also used to treat bone loss in men and women receiving certain cancer treatments and to treat giant cell tumor of bone in adults and adolescents.
What are the common side effects of Prolia?
Common side effects associated with Prolia include pain in the extremities, muscle spasms, constipation, and urinary tract infections. Less common but more serious side effects can also occur.
How is Prolia administered?
Prolia is given as an injection under the skin (subcutaneously) typically once every six months by a healthcare professional.
Sources:
1. https://drugpatentwatch.com/